Drug Profile
Hydroxyzine
Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Tufts University; University of California at San Francisco
- Class Antiallergics; Anxiolytics; Piperazines; Sedating antihistamines
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Multiple sclerosis
Most Recent Events
- 25 Oct 2002 Phase-II clinical trials in Multiple sclerosis in USA (unspecified route)